Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. [electronic resource]
- Lancet (London, England) Dec 1969
- 1401-2 p. digital
Publication Type: Journal Article
0140-6736
10.1016/s0140-6736(69)90940-4 doi
Adolescent Chelating Agents--therapeutic use Chlorides Copper--metabolism Ethylenediamines--therapeutic use Hepatolenticular Degeneration--drug therapy Humans Male Nephrotic Syndrome--chemically induced Neurologic Manifestations Penicillamine--adverse effects